Regeneron and Sanofi’s blockbuster Dupixent has transformed the atopic dermatitis market, with future disruptors in the ...

A large new study finds that early-life exposure to dogs may reduce the genetic risk of developing eczema in children, ...

The trial is designed to assess the therapy's efficacy when administered subcutaneously in single ascending doses.

Those that know, know: Atopic dermatitis, otherwise known as eczema, is no walk in the park—especially for Black folks. According to the National Eczema Association, African Americans are more likely ...

Women are more prone to the condition than men, and Black and Latinx people tend to have more persistent and severe symptoms ...

Bosakitug is a Potential Best-in-Class Investigational Monoclonal Antibody with Demonstrated Superior Potency, Residence Time ...

Karyn Flett first began using steroid treatment when she was 10 - 40 years on she says it has 'ruined her life' ...

Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2 All three cohorts show separation from placebo ...

A new analysis suggests artificial intelligence algorithms are able to accurately assess lesion severity in patients with ...

Anti-OX40 medications have been associated with positive efficacy and safety outcomes for the treatment of atopic dermatitis.

For the new AI, researchers gathered data from an eczema tracking app called Atopiyo that is popular in Japan. More than ...